Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease

Details for Australian Patent Application No. 2006300485 (hide)

Owner Kyorin Pharmaceutical Co., Ltd.

Inventors Kobayashi, Eiji; Yasue, Tokutarou; Kaneko, Takashi

Agent Griffith Hack

Pub. Number AU-B-2006300485

PCT Pub. Number WO2007/043433

Priority 2005-295478 07.10.05 JP

Filing date 5 October 2006

Wipo publication date 19 April 2007

Acceptance publication date 25 August 2011

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/043433 Priority application(s): WO2007/043433

25 August 2011 Application Accepted

  Published as AU-B-2006300485

22 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006300492-Process for producing 1-benzyl-4-[(5,6-dimethoxy-1indanon)-2 -yl]methylpiperidine or hydrochloride thereof

2006300478-Dermatitis treating agent